HYPOTHESIS: Adenoviral-mediated (AdV-T2) overexpression of TIMP-2 would blunt ventricular remodeling and improve survival in a murine model of chronic ischemic injury. METHODS: Male mice (n = 124) aged 10-14 weeks underwent either (1) left coronary artery ligation to induce myocardial infarction (MI group, n = 36), (2) myocardial injection of 6 × 10¹⁰ viral particles of AdV-T2 immediately post-MI (MI + T2 group, n = 30), (3) myocardial injection of 6 × 10¹⁰ viral particles of a control adenovirus (MI + Ct, n = 38), or 4) received no intervention (controls, n = 20). On post-MI day 7, surviving mice (n = 79) underwent echocardiographic, immunohistochemical, and biochemical analysis. RESULTS: In infarcted animals, the MI + T2 group demonstrated improved survival (p < 0.02), better preservation of developed pressure and ventricular diameter (p < 0.04), and the lowest expression and activity of MMP-2 and MMP-9 (p < 0.04) compared with MI and MI + Ct groups. All infarcted hearts displayed significantly increased inflammatory cell infiltration (p < 0.04 vs. control, MI, or MI + T2), with infiltration highest in the MI + Ct group and lowest in the MI + T2 group (p < 0.04). CONCLUSIONS: Adenoviral mediated myocardial delivery of the TIMP-2 gene improves post-MI survival and limits adverse remodeling in a murine model of MI.
HYPOTHESIS: Adenoviral-mediated (AdV-T2) overexpression of TIMP-2 would blunt ventricular remodeling and improve survival in a murine model of chronic ischemic injury. METHODS: Male mice (n = 124) aged 10-14 weeks underwent either (1) left coronary artery ligation to induce myocardial infarction (MI group, n = 36), (2) myocardial injection of 6 × 10¹⁰ viral particles of AdV-T2 immediately post-MI (MI + T2 group, n = 30), (3) myocardial injection of 6 × 10¹⁰ viral particles of a control adenovirus (MI + Ct, n = 38), or 4) received no intervention (controls, n = 20). On post-MI day 7, surviving mice (n = 79) underwent echocardiographic, immunohistochemical, and biochemical analysis. RESULTS: In infarcted animals, the MI + T2 group demonstrated improved survival (p < 0.02), better preservation of developed pressure and ventricular diameter (p < 0.04), and the lowest expression and activity of MMP-2 and MMP-9 (p < 0.04) compared with MI and MI + Ct groups. All infarcted hearts displayed significantly increased inflammatory cell infiltration (p < 0.04 vs. control, MI, or MI + T2), with infiltration highest in the MI + Ct group and lowest in the MI + T2 group (p < 0.04). CONCLUSIONS: Adenoviral mediated myocardial delivery of the TIMP-2 gene improves post-MI survival and limits adverse remodeling in a murine model of MI.
Authors: Michael P Hudson; Paul W Armstrong; Witold Ruzyllo; Jose Brum; Lisa Cusmano; Piotr Krzeski; Robert Lyon; Miguel Quinones; Pierre Theroux; Diana Sydlowski; Henry E Kim; Mario J Garcia; Wael A Jaber; W Douglas Weaver Journal: J Am Coll Cardiol Date: 2006-06-21 Impact factor: 24.094
Authors: L E Rohde; A Ducharme; L H Arroyo; M Aikawa; G H Sukhova; A Lopez-Anaya; K F McClure; P G Mitchell; P Libby; R T Lee Journal: Circulation Date: 1999-06-15 Impact factor: 29.690
Authors: Ravi Ramani; Michael Mathier; Ping Wang; Gregory Gibson; Sandra Tögel; Jennifer Dawson; Anthony Bauer; Sean Alber; Simon C Watkins; Charles F McTiernan; Arthur M Feldman Journal: Am J Physiol Heart Circ Physiol Date: 2004-09 Impact factor: 4.733
Authors: Hai Tian; Massimo Cimini; Paul W M Fedak; Svetlana Altamentova; Shafie Fazel; Ming-Li Huang; Richard D Weisel; Ren-Ke Li Journal: J Mol Cell Cardiol Date: 2007-09-14 Impact factor: 5.000
Authors: Amanda R Kaminski; Edwin T Moore; Michael J Daseke; Fritz M Valerio; Elizabeth R Flynn; Merry L Lindsey Journal: Am J Physiol Heart Circ Physiol Date: 2020-02-21 Impact factor: 4.733
Authors: S Givvimani; S Kundu; N Narayanan; F Armaghan; N Qipshidze; S Pushpakumar; T P Vacek; S C Tyagi Journal: Arch Physiol Biochem Date: 2013-02-11 Impact factor: 4.076
Authors: Diana S Nascimento; Mariana Valente; Tiago Esteves; Maria de Fátima de Pina; Joana G Guedes; Ana Freire; Pedro Quelhas; Perpétua Pinto-do-Ó Journal: PLoS One Date: 2011-09-30 Impact factor: 3.240